“The European nerve repair and regeneration market comprises various types of products that can be segmented into nerve repair by biomaterials and nerve repair by neurostimulation, of which nerve repair by neurostimulation holds the highest market share of 66.4%, followed by nerve repair by biomaterials with a market share of 33.6%.
The European nerve repair and regeneration market displays growth that is projected to grow at a CAGR of 11.9% by 2019. This growth is driven by a number of drivers such as technological advancements and increasing number of neuro injuries that have provided a whole lot of growth opportunities for the market.
In the European region, the maximum market share is held by Germany and France; there has been a growth trend in this region over the past few years, due to the increasing diseases related to nerves such as Parkinson’s and epilepsy, as these are the major application areas for the devices; however, nerve repair by neurostimulation is widely used. The report focuses on an in-depth growth analysis in terms of market values in the respective geography and the market share of various companies that excel in these areas.
Technological advancements have been a backbone in increasing the market, which has been deeply analysed and added in the report. Due to the increasing demand and potential for these devices, the government has also extended its support; however, some stringent rules and regulations such as the implementation of taxes may still hamper the growth in the market.
A competitive analysis of the reports has been provided on the basis of companies that have been worked through diagrams and pie charts. It involves leaders such as Integra life sciences Corporation, Axogen, Stryker, Baxter International Inc., etc.
”
“TABLE OF CONTENTS
1 INTRODUCTION 8
1.1 OBJECTIVES OF THE STUDY 8
1.2 MARKET SEGMENTATION & COVERAGE 8
1.3 STAKEHOLDERS 9
2 RESEARCH METHODOLOGY 10
2.1 INTEGRATED ECOSYSTEM OF THE NERVE REPAIR AND REGENERATION MARKET 10
2.1.1 TOP-DOWN APPROACH 11
2.1.2 BOTTOM-UP APPROACH 11
2.1.3 MACRO INDICATOR-BASED APPROACH 12
2.2 ASSUMPTIONS 13
3 EXECUTIVE SUMMARY 14
4 MARKET OVERVIEW 15
4.1 INTRODUCTION 15
4.2 NERVE REPAIR AND REGENERATION MARKET: COMPARISON WITH PARENT MARKET 16
4.3 MARKET DRIVERS AND INHIBITORS 16
4.4 KEY MARKET DYNAMICS 18
5 NERVE REPAIR AND REGENERATION MARKET, BY TYPE 19
5.1 INTRODUCTION 20
5.2 NERVE REPAIR AND REGENERATION MARKET, TYPE COMPARISON WITH PARENT MARKET 21
5.3 EUROPE NERVE REPAIR BY BIOMATERIALS, BY GEOGRAPHY 22
5.4 EUROPE NERVE REPAIR BY NEUROSTIMULATION, BY GEOGRAPHY 23
6 NERVE REPAIR AND REGENERATION MARKET, BY GEOGRAPHY 24
6.1 INTRODUCTION 25
6.2 GERMANY: NERVE REPAIR AND REGENERATION MARKET, BY TYPE 26
6.3 FRANCE: NERVE REPAIR AND REGENERATION MARKET, BY TYPE 28
6.4 U.K.: NERVE REPAIR AND REGENERATION MARKET, BY TYPE 30
6.5 ITALY: NERVE REPAIR AND REGENERATION MARKET, BY TYPE 31
6.6 SPAIN: NERVE REPAIR AND REGENERATION MARKET, BY TYPE 33
7 NERVE REPAIR AND REGENERATION MARKET: COMPETITIVE LANDSCAPE 35
7.1 NERVE REPAIR AND REGENERATION MARKET: COMPANY SHARE ANALYSIS 35
7.2 MERGERS & ACQUISITIONS 36
7.3 EXPANSIONS 36
8 NERVE REPAIR AND REGENERATION MARKET, BY COMPANY 38
8.1 INTEGRA LIFE SCIENCES CORP. 38
8.1.1 OVERVIEW 38
8.1.2 KEY FINANCIALS 39
8.1.3 PRODUCT AND SERVICE OFFERINGS 39
8.1.4 RELATED DEVELOPMENTS 40
8.2 AXOGEN, INC. 41
8.2.1 OVERVIEW 41
8.2.2 KEY FINANCIALS 41
8.2.3 PRODUCT AND SERVICE OFFERINGS 41
8.2.4 RELATED DEVELOPMENTS 42
8.3 POLYGANICS. 43
8.3.1 OVERVIEW 43
8.3.2 KEY FINANCIALS 43
8.3.3 PRODUCT AND SERVICE OFFERINGS 43
8.3.4 RELATED DEVELOPMENTS 44
8.4 STRYKER 45
8.4.1 OVERVIEW 45
8.4.2 KEY FINANCIALS 45
8.4.3 PRODUCT AND SERVICE OFFERINGS 46
8.4.4 RELATED DEVELOPMENTS 46
8.5 ST. JUDE MEDICAL 47
8.5.1 OVERVIEW 47
8.5.2 KEY FINANCIALS 47
8.5.3 PRODUCT AND SERVICE OFFERINGS 48
8.5.4 RELATED DEVELOPMENTS 48
8.6 MEDTRONIC PLC 49
8.6.1 OVERVIEW 49
8.6.2 KEY FINANCIALS 49
8.6.3 PRODUCT AND SERVICE OFFERINGS 50
8.6.4 RELATED DEVELOPMENTS 50
9 APPENDIX 51
9.1 CUSTOMIZATION OPTIONS 51
9.1.1 TECHNICAL ANALYSIS 51
9.1.2 LOW-COST SOURCING LOCATIONS 51
9.1.3 REGULATORY FRAMEWORK 51
9.1.4 IMPACT ANALYSIS 51
9.1.5 HISTORICAL DATA AND TRENDS 51
9.2 RELATED REPORTS 52
9.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 53
9.3.1 RT SNAPSHOTS 54
“
“LIST OF TABLES
UU
TABLE 1 EUROPE NERVE REPAIR AND REGENERATION MARKET: HEALTHCARE EXPENDITURE,
BY GEOGRAPHY, 2014 13
TABLE 2 NERVE REPAIR AND REGENERATION: COMPARISON WITH PARENT MARKET,
2013-2019 (USD MN) 16
TABLE 3 EUROPE NERVE REPAIR & REGENERATION MARKET DRIVERS AND INHIBITORS 16
TABLE 4 EUROPE NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN) 18
TABLE 5 EUROPE NERVE REPAIR AND REGENERATION MARKET, BY GEOGRAPHY,
2013-2019 (USD MN) 18
TABLE 6 EUROPE NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN) 20
TABLE 7 EUROPE NERVE REPAIR AND REGENERATION MARKET: TYPE COMPARISON WITH PARENT MARKET, 2013-2019 (USD MN) 21
TABLE 8 EUROPE NERVE REPAIR BY BIOMATERIALS MARKET, BY GEOGRAPHY,
2013-2019 (USD MN) 22
TABLE 9 EUROPE NERVE REPAIR BY NEUROSTIMULATION, BY GEOGRAPHY, 2013-2019 (USD MN) 23
TABLE 10 EUROPE NERVE REPAIR AND REGENERATION MARKET, BY GEOGRAPHY,
2013-2019 (USD MN) 26
TABLE 11 GERMANY: NERVE REPAIR AND REGENERATION MARKET, BY TYPE,
2013-2019 (USD MN) 27
TABLE 12 FRANCE: NERVE REPAIR AND REGENERATION MARKET, BY TYPE,
2013 – 2019 (USD MN) 28
TABLE 13 U.K.: NERVE REPAIR AND REGENERATION : MARKET, BY TYPE, 2013-2019 (USD MN) 30
TABLE 14 ITALY: NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN) 32
TABLE 15 SPAIN: NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN) 33
TABLE 16 NERVE REPAIR AND REGENERATION MARKET: COMPANY SHARE ANALYSIS, 2013 (%) 35
TABLE 17 EUROPE NERVE REPAIR AND REGENERATION MARKET: MERGERS & ACQUISITIONS 36
TABLE 18 EUROPE NERVE REPAIR AND REGENERATION MARKET: EXPANSIONS 36
TABLE 19 INTEGRA LIFE SCIENCES CORP: KEY FINANCIALS, 2008-2013 (USD MN) 39
TABLE 20 AXOGEN, INC : KEY FINANCIALS, 2009-2013 (USD MN) 41
TABLE 21 STRYKER: KEY FINANCIALS, BY GEOGRAPHY, 2009 – 2013 (USD MN) 45
TABLE 22 ST. JUDE MEDICAL: KEY FINANCIALS, 2009-2013 (USD MN) 47
TABLE 23 MEDTRONIC PLC: KEY FINANCIALS, 2009-2013 (USD MN) 49
“
“LIST OF FIGURES
FIGURE 1 EUROPE NERVE REPAIR AND REGENERATION MARKET SEGMENTATION & COVERAGE 9
FIGURE 2 NERVE REPAIR AND REGENERATION MARKET: INTEGRATED ECOSYSTEM 10
FIGURE 3 TOP-DOWN APPROACH 11
FIGURE 4 BOTTOM-UP APPROACH 12
FIGURE 5 MACRO INDICATOR-BASED APPROACH 2014 13
FIGURE 6 EUROPEAN NERVE REPAIR AND REGENERATION MARKET SNAPSHOT – 2014 14
FIGURE 7 EUROPE NERVE REPAIR AND REGENERATION TYPES, BY GEOGRAPHY, 2013 (USD MN) 18
FIGURE 8 EUROPE NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN) 20
FIGURE 9 EUROPE NERVE REPAIR AND REGENERATION MARKET: TYPE COMPARISON WITH PARENT MARKET, 2013-2019 (USD MN) 21
FIGURE 10 EUROPE NERVE REPAIR BY BIOMATERIALS MARKET, BY GEOGRAPHY,
2013-2019 (USD MN) 22
FIGURE 11 EUROPE NERVE REPAIR BY NEUROSTIMULATION MARKET, BY GEOGRAPHY,
2013-2019 (USD MN) 23
FIGURE 12 EUROPEAN NERVE REPAIR AND REGENERATION MARKET: GROWTH ANALYSIS,
BY GEOGRAPHY, 2013-2019 (USD MN) 25
FIGURE 13 GERMANY: NERVE REPAIR AND REGENERATION, BY TYPE, 2013-2019 (USD MN) 26
FIGURE 14 GERMANY: NERVE REPAIR AND REGENERATION MARKET SHARE, BY TYPE,
2014-2019 (%) 27
FIGURE 15 FRANCE: NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN) 28
FIGURE 16 FRANCE: NERVE REPAIR AND REGENERATION MARKET SHARE, BY TYPE, 2014-2019 (%) 29
FIGURE 17 U.K.: NERVE REPAIR AND REGENERATION MARKET, BY TYPE , 2013-2019 (USD MN) 30
FIGURE 18 U.K.: NERVE REPAIR AND REGENERATION MARKET: TYPE SNAPSHOT 2014 – 2019 31
FIGURE 19 ITALY NERVE REPAIR AND REGENERATION MARKET, BY TYPE , 2013-2019 (USD MN) 31
FIGURE 20 ITALY: NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2014-2019 32
FIGURE 21 SPAIN: NERVE REPAIR AND REGENERATION MARKET, BY TYPE , 2013-2019 (USD MN) 33
FIGURE 22 SPAIN: NERVE REPAIR AND REGENERATION MARKET, BY TYPE 2014 & 2019 34
FIGURE 23 NERVE REPAIR AND REGENERATION: COMPANY SHARE ANALYSIS, 2013 (%) 35
FIGURE 24 INTEGRA LIFE SCIENCES HOLDINGS CORP.: REVENUE MIX, 2013 (%) 38
FIGURE 25 CONTRIBUTION OF THE NEUROSURGERY SEGMENT TOWARDS COMPANY REVENUES, 2008-2013 (USD MN) 39
FIGURE 26 STRYKER: REVENUE MIX, 2013 (%) 45
FIGURE 27 ST. JUDE MEDICAL, REVENUE MIX, 2013 (%) 47
FIGURE 28 MEDTRONIC PLC REVENUE MIX 2013 (%) 49
“
